63 results
Page 3 of 4
8-K
uhzpuo
29 May 20
Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTACĀ® Protein Degrader
7:06am
8-K
EX-1.1
6dxv8 jieapcyv
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
424B5
bw8407yam35qn bx57u
7 Nov 19
Prospectus supplement for primary offering
4:05pm
424B5
87p3b wxa1lg
6 Nov 19
Prospectus supplement for primary offering
5:31pm
DEF 14A
fip365oiqyt97vv
12 Apr 19
Definitive proxy
5:02pm
10-K
bjz 4xjqw99r2a8843v
26 Mar 19
Annual report
4:31pm
10-Q
7vei57ll5 d7qesxhr
14 Nov 18
Quarterly report
12:00am